These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37238637)

  • 1. CVAM: CNA Profile Inference of the Spatial Transcriptome Based on the VGAE and HMM.
    Ma J; Guo J; Fan Z; Zhao W; Zhou X
    Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLImAT-HET: detecting subclonal copy number alterations and loss of heterozygosity in heterogeneous tumor samples from whole-genome sequencing data.
    Yu Z; Li A; Wang M
    BMC Med Genomics; 2017 Mar; 10(1):15. PubMed ID: 28298214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific genomic regions are differentially affected by copy number alterations across distinct cancer types, in aggregated cytogenetic data.
    Kumar N; Cai H; von Mering C; Baudis M
    PLoS One; 2012; 7(8):e43689. PubMed ID: 22937079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copy number losses of oncogenes and gains of tumor suppressor genes generate common driver mutations.
    Besedina E; Supek F
    Nat Commun; 2024 Jul; 15(1):6139. PubMed ID: 39033140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of genomic copy number alteration emphasizing a restriction site-based strategy of genome re-sequencing.
    Zheng C; Miao X; Li Y; Huang Y; Ruan J; Ma X; Wang L; Wu CI; Cai J
    Bioinformatics; 2013 Nov; 29(22):2813-21. PubMed ID: 23962614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. rcCAE: a convolutional autoencoder method for detecting intra-tumor heterogeneity and single-cell copy number alterations.
    Yu Z; Liu F; Shi F; Du F
    Brief Bioinform; 2023 May; 24(3):. PubMed ID: 36961311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integrated approach to reveal miRNAs' impacts on the functional consequence of copy number alterations in cancer.
    Li K; Liu Y; Zhou Y; Zhang R; Zhao N; Yan Z; Zhang Q; Zhang S; Qiu F; Xu Y
    Sci Rep; 2015 Jun; 5():11567. PubMed ID: 26099552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
    Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
    Elife; 2020 May; 9():. PubMed ID: 32401198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copy number alteration and uniparental disomy analysis categorizes Japanese papillary thyroid carcinomas into distinct groups.
    Matsuse M; Sasaki K; Nishihara E; Minami S; Hayashida C; Kondo H; Suzuki K; Saenko V; Yoshiura K; Mitsutake N; Yamashita S
    PLoS One; 2012; 7(4):e36063. PubMed ID: 22558328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis.
    Wang G; Anastassiou D
    Sci Rep; 2020 Oct; 10(1):17199. PubMed ID: 33057153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hierarchical discovery of large-scale and focal copy number alterations in low-coverage cancer genomes.
    Khalil AIS; Khyriem C; Chattopadhyay A; Sanyal A
    BMC Bioinformatics; 2020 Apr; 21(1):147. PubMed ID: 32299346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies.
    Parisi F; Ariyan S; Narayan D; Bacchiocchi A; Hoyt K; Cheng E; Xu F; Li P; Halaban R; Kluger Y
    BMC Genomics; 2011 May; 12():230. PubMed ID: 21569352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. iGC-an integrated analysis package of gene expression and copy number alteration.
    Lai YP; Wang LB; Wang WA; Lai LC; Tsai MH; Lu TP; Chuang EY
    BMC Bioinformatics; 2017 Jan; 18(1):35. PubMed ID: 28088185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDCOCA: a statistical method to define complexity dependence of co-occuring chromosomal aberrations.
    Kumar N; Rehrauer H; Cai H; Baudis M
    BMC Med Genomics; 2011 Mar; 4():21. PubMed ID: 21371302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic and prognostic heterogeneity among RAS/BRAF
    Berg KCG; Brunsell TH; Sveen A; Alagaratnam S; Bjørnslett M; Hektoen M; Brudvik KW; Røsok BI; Bjørnbeth BA; Nesbakken A; Lothe RA
    Mol Oncol; 2021 Apr; 15(4):830-845. PubMed ID: 33325154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death.
    Hieronymus H; Murali R; Tin A; Yadav K; Abida W; Moller H; Berney D; Scher H; Carver B; Scardino P; Schultz N; Taylor B; Vickers A; Cuzick J; Sawyers CL
    Elife; 2018 Sep; 7():. PubMed ID: 30178746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component.
    Alonso MH; Aussó S; Lopez-Doriga A; Cordero D; Guinó E; Solé X; Barenys M; de Oca J; Capella G; Salazar R; Sanz-Pamplona R; Moreno V
    Br J Cancer; 2017 Jul; 117(3):421-431. PubMed ID: 28683472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The repertoire of copy number alteration signatures in human cancer.
    Tao Z; Wang S; Wu C; Wu T; Zhao X; Ning W; Wang G; Wang J; Chen J; Diao K; Chen F; Liu XS
    Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36806386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of methods to detect copy number alterations in cancer using simulated and real genotyping data.
    Mosén-Ansorena D; Aransay AM; Rodríguez-Ezpeleta N
    BMC Bioinformatics; 2012 Aug; 13():192. PubMed ID: 22870940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.